Dashboard
Manage Tickers

SWTX SpringWorks Therapeutics, Inc.


$ 46.99 $ 0.01 (0.02 %)    

Monday, 30-Jun-2025 16:31:18 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 590.67 $ 4.40 (0.75 %)
DIA $ 462.73 $ 5.05 (1.1 %)
SPY $ 659.11 nm (nm)
TLT $ 89.49 nm (nm)
GLD $ 373.39 $ -0.58 (-0.15 %)
$ 46.99
$ 46.99
$ 0.00 x 0
$ 0.00 x 0
-- - --
$ 28.21 - $ 62.00
5,010,844
na
3.54B
$ 0.75
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

legendary-investor-stanley-druckenmiller-made-huge-ai-and-chipmaker-bets-in-q2--heres-what-he-knows-that-you-dont
Legendary Investor Stanley Druckenmiller M...
08/18/2025 08:15:39

See Stanley Druckenmiller's Q2 13F filing. Duquesne adds Microsoft and big banks, cuts Coupang, and makes a bullish bet on ...

springworks-therapeutics-receives-ec-conditional-marketing-approval-for-ezmekly-in-treating-nf1-pn-across-pediatric-and-adult-patients
SpringWorks Therapeutics Receives EC Condi...
07/18/2025 16:14:43

SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany, announced today that the European Commi...

california-rep-gilbert-ray-cisneros-sold-over-28k-worth-of-springworks-therapeutics-inc-ordinary-shares-stock-heres-what-you-should-know
California Rep. Gilbert Ray Cisneros Sold ...
07/11/2025 15:00:15

springworks-therapeutics-receives-positive-ema-chmp-opinion-recommending-approval-of-cos-nirogacestat-in-adults-with-desmoid-tumors
SpringWorks Therapeutics Receives Positive...
06/20/2025 12:04:00

springworks-therapeutics-secures-ema-chmp-endorsement-for-conditional-approval-of-mirdametinib-in-nf1-pn-treatment
SpringWorks Therapeutics Secures EMA CHMP ...
05/23/2025 12:04:12

– If approved, mirdametinib is expected to be the first and only therapy in the European Union with marketing authorization for...

guggenheim-reiterates-neutral-on-springworks-therapeutics-maintains-47-price-target
Guggenheim Reiterates Neutral on SpringWor...
05/12/2025 14:07:13

Guggenheim analyst Michael Schmidt reiterates SpringWorks Therapeutics (NASDAQ:SWTX) with a Neutral and maintains $47 price ...

hc-wainwright--co-downgrades-springworks-therapeutics-to-neutral-lowers-price-target-to-47
HC Wainwright & Co. Downgrades SpringWorks...
04/30/2025 12:41:17

HC Wainwright & Co. analyst Robert Burns downgrades SpringWorks Therapeutics (NASDAQ:SWTX) from Buy to Neutral and lower...

correction-guggenheim-downgrades-springworks-therapeutics-to-neutral-lowers-price-target-to-47-firm-change-from-stephens--co-to-guggenheim
Correction: Guggenheim Downgrades SpringWo...
04/29/2025 14:47:27

Correction: Guggenheim analyst Michael Schmidt downgrades SpringWorks Therapeutics (NASDAQ:SWTX) from Buy to Neutral and lowers...

td-cowen-downgrades-springworks-therapeutics-to-hold-lowers-price-target-to-47
TD Cowen Downgrades SpringWorks Therapeuti...
04/29/2025 12:31:38

TD Cowen analyst Yaron Werber downgrades SpringWorks Therapeutics (NASDAQ:SWTX) from Buy to Hold and lowers the price target...

analyst-expectations-for-springworks-therapeuticss-future
Analyst Expectations For SpringWorks Thera...
04/28/2025 21:00:26

barclays-downgrades-springworks-therapeutics-to-equal-weight-lowers-price-target-to-47
Barclays Downgrades SpringWorks Therapeuti...
04/28/2025 17:28:39

Barclays analyst Peter Lawson downgrades SpringWorks Therapeutics (NASDAQ:SWTX) from Overweight to Equal-Weight and lowers t...

merck-germany-buys-us-cancer-drugmaker-springworks-therapeutics-for-around-4-billion
Merck Germany Buys US Cancer Drugmaker Spr...
04/28/2025 16:17:58

Merck & Company, Inc. (MRK) to acquire SpringWorks Therapeutics, Inc. (SWTX) for $47/share in cash, creating synergies for ...

reported-sunday-springworks-anticipates-ema-chmp-ruling-on-nirogacestat-for-desmoid-tumor-therapy-in-q2-2025
Reported Sunday, SpringWorks Anticipates E...
04/28/2025 06:37:26

Core News & Articles
SpringWorks Therapeutics To Be Acquired by...
04/28/2025 06:35:26

Purchase price of $47 per share in cash represents an equity value of approximately $3.9 billion, or an enterprise value of $3....

germanys-merck-nears-roughly-35-billion-deal-for-springworks-merck-and-springworks-have-agreed-on-a-price-close-to-47-per-share---wsj
'Germany's Merck Nears Roughly $3.5 Billio...
04/24/2025 19:10:35

https://www.wsj.com/business/deals/germanys-merck-nears-roughly-3-5-billion-deal-for-springworks-2c7258b9

correction-watching-springworks-therapeutics-barclays-out-with-note-says-april-chmp-agenda-out-ogsiveo-meeting-today-422-could-de-risk-potential-ma-by-merck-kgaa
CORRECTION: Watching SpringWorks Therapeut...
04/22/2025 15:05:14

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
02/27/2025 17:35:23

assessing-springworks-therapeutics-insights-from-6-financial-analysts
Assessing SpringWorks Therapeutics: Insigh...
02/24/2025 14:01:22

hc-wainwright--co-reiterates-buy-on-springworks-therapeutics-maintains-74-price-target
HC Wainwright & Co. Reiterates Buy on Spri...
02/24/2025 12:15:24

HC Wainwright & Co. analyst Robert Burns reiterates SpringWorks Therapeutics (NASDAQ:SWTX) with a Buy and maintains $74 ...

hc-wainwright--co-reiterates-buy-on-springworks-therapeutics-maintains-74-price-target
HC Wainwright & Co. Reiterates Buy on Spri...
02/21/2025 18:28:52

HC Wainwright & Co. analyst Robert Burns reiterates SpringWorks Therapeutics (NASDAQ:SWTX) with a Buy and maintains $74 ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION